Cornerstone Capital Management Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-25,400
Closed -$675K 1355
2016
Q3
$675K Buy
25,400
+5,200
+26% +$138K 0.01% 1021
2016
Q2
$446K Sell
20,200
-62,651
-76% -$1.38M ﹤0.01% 1059
2016
Q1
$2.43M Buy
82,851
+50,000
+152% +$1.47M 0.02% 674
2015
Q4
$1.09M Buy
32,851
+17,551
+115% +$580K 0.01% 877
2015
Q3
$553K Sell
15,300
-16,300
-52% -$589K 0.01% 985
2015
Q2
$1.42M Buy
31,600
+27,900
+754% +$1.25M 0.01% 813
2015
Q1
$113K Buy
+3,700
New +$113K ﹤0.01% 1255
2013
Q4
Sell
-5,200
Closed -$119K 1271
2013
Q3
$119K Buy
+5,200
New +$119K ﹤0.01% 1108